Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study-Reference-Cited by-同舟云学术

Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study

Published:2012-11 Issue:11 Volume:13 Page:1114-1124
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Olmos David,Brewer Daniel,Clark Jeremy,Danila Daniel C,Parker Chris,Attard Gerhardt,Fleisher Martin,Reid Alison HM,Castro Elena,Sandhu Shahneen K,Barwell Lorraine,Oommen Nikhil Babu,Carreira Suzanne,Drake Charles G,Jones Robert,Cooper Colin S,Scher Howard I,de Bono Johann S

Publisher

Elsevier BV

Subject

Oncology

Reference38 articles.

1. Treatment of localized prostate cancer: when is active surveillance appropriate?;Albertsen;Nat Rev Clin Oncol,2010

2. CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer;Ang;Br J Cancer,2009

3. Blood and tissue biomarkers in prostate cancer: state of the art;Fiorentino;Urol Clin North Am,2010

4. Targeting IGF-1R: throwing out the baby with the bathwater?;Basu;Br J Cancer,2011

5. Cell-free nucleic acids as biomarkers in cancer patients;Schwarzenbach;Nat Rev Cancer,2011

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene expression signature of castrate resistant prostate cancer;Gene;2024-10

2. Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate Cancer;Cancers;2024-07-14

3. Development of a multigenomic liquid biopsy (PROSTest) for prostate cancer in whole blood;The Prostate;2024-04-03

4. Systematic review and integrated analysis of prognostic gene signatures for prostate cancer patients;Discover Oncology;2023-12-19

5. Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance;Nature;2023-10-16